Horizon Pharma

^{, Nasdaq: HZNP}

Launching DUEXIS for pain relief in rheumatoid arthritis/osteoarthritis patients.

Industry: Health Care

First Day Return: +1.7%

HZNP

Launching DUEXIS for pain relief in rheumatoid arthritis/osteoarthritis patients.

IPO News for Horizon Pharma

Horizon Pharma quiet period ends September 6 09/01/11
Consumer IPOs defy bad economic data 08/01/11
Horizon Pharma prices IPO at $9, below the range 07/27/11

IPO Data
IPO Date	07/27/2011
Offer Price	IPO Intelligence Only
Price Range	IPO Intelligence Only
Offer Shares (mm)	IPO Intelligence Only
Deal Size ($mm)	$50
Lock-Up Date	IPO Intelligence Only
Street Research	IPO Intelligence Only

Underwriters
IPO Intelligence Only

Company Data
Website www.horizonpharma.com
Headquarters	Northbrook, IL, United States
Founded	2005
Employees at IPO	39

IPO News for Horizon Pharma

Horizon Pharma quiet period ends September 6 09/01/11
Consumer IPOs defy bad economic data 08/01/11
Horizon Pharma prices IPO at $9, below the range 07/27/11

Horizon Pharma (HZNP) Performance